Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

2005409 citationsJournal Articlegreen Open Access

Authors

L johnsonii LA1 (4 x 10(9) cfu/day) did not have a sufficient effect, if any, to prevent endoscopic recurrence of Crohn's disease.

Good health and well-being

Published in: Gut

Volume 55, Issue 6, pp. 842-847

Field-Weighted Citation Impact: 15.13